Sepsis is a life-threatening organ dysfunction condition caused by a dysregulated response to an infection that is common among patients with moderate to severe burn injury. Previously, genomic variants in Toll-like receptor 4 (TLR4), a key innate immunity receptor, have been associated with sepsis and infection susceptibility. In this study, the association of six TLR4 SNPs with sepsis after burn injury was tested in the Mexican mestizo population. We found that the rs2737190 polymorphism is associated with sepsis after burn trauma. Interestingly, the G allele and GG genotype were associated with a lower risk of developing sepsis. Since the rs2737190 SNP is in the promoter region of the TLR4 gene, we analyzed the possibility that this polymorphism regulates the TLR4 pathway. We cultured peripheral blood mononuclear cells from different genotype carriers and found, after stimulation with LPS, that carriers of the GG genotype showed a higher expression of TLR4, IL6, and TNFα than AA genotype carriers. The results suggest that the GG genotype produces an increase in the TLR4 expression, and therefore an improvement in the immune response. We conclude that the rs2737190 polymorphism may become a useful marker for genetic studies of sepsis in patients after a burn injury.
Subscribe to Journal
Get full journal access for 1 year
only $14.88 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Peck M, Molnar J, Swart D. A global plan for burn prevention and care. Bull World Health Organ. 2009;87:802–3.
Artero A, Zaragoza R, Camarena JJ, Sancho S, González R, Nogueira JM. Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock. J Crit Care. 2010;25:276–81.
Duke J, Wood F, Semmens J, Edgar DW, Spilsbury K, Willis A, et al. Rates of hospitalisations and mortality of older adults admitted with burn injuries in Western Australian from 1983 to 2008. Australas J Ageing. 2012;31:83–9.
Fleischmann C, Scherag A, Adhikari NKJ, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016;193:259–72.
Barber RC, Chang LY, Purdue GF, Hunt JL, Arnoldo BD, Aragaki CC, et al. Detecting genetic predisposition for complicated clinical outcomes after burn injury. Burns 2006;32:821–7.
Sørensen TIA, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med. 1988;318:727–32.
Rafla K, Tredget EE. Infection control in the burn unit. Burns 2011;37:5–15.
Thompson C, Holden T, Rona G, Laxmanan B, Black R, O’Keefe G, et al. Toll-like receptor 1 polymorphisms and associated outcomes in sepsis after traumatic injury: a Candidate Gene Association Study. Ann Surg. 2013;259:179–85.
Gibot S, Cariou A, Drouet L, Rossignol M, Ripoll L. Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med. 2002;30:969–73.
Baier J, Loggins J, Yanamandra K. IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated very low birth weight infants. BMC Med. 2006;4:10.
Cardinal-Fernández P, Ferruelo A, El-Assar M, Santiago C, Gómez-Gallego F, Martín-Pellicer A, et al. Genetic predisposition to acute kidney injury induced by severe sepsis. J Crit Care. 2013;28:365–70.
Shao Y, He J, Chen F, Cai Y, Zhao J, Lin Y, et al. Association study between promoter polymorphisms of ADAM17 and progression of sepsis. Cell Physiol Biochem. 2016;39:1247–61.
He J, Chen Y, Lin Y, Zhang W, Cai Y, Chen F, et al. Association study of MCP-1 promoter polymorphisms with the susceptibility and progression of sepsis. PLoS ONE. 2017;12:e0176781.
Vilander L, Kaunisto M, Vaara S, Pettilä V. Genetic variants in SERPINA4 and SERPINA5, but not BCL2 and SIK3 are associated with acute kidney injury in critically ill patients with septic shock. Crit Care. 2017;21:47.
Mao Z-R, Zhang S-L, Feng B. Association of IL-10 (-819T/C, -592A/C and -1082A/G) and IL-6 -174G/C gene polymorphism and the risk of pneumonia-induced sepsis. Biomarkers. 2017;22:106–12.
Accardo Palumbo A, Forte GI, Pileri D, Vaccarino L, Conte F, D’Amelio L, et al. Analysis of IL-6, IL-10 and IL-17 genetic polymorphisms as risk factors for sepsis development in burned patients. Burns. 2012;38:208–13.
Barber R, Aragaki C, Purdue G, Hunt J, Arnoldo B, Horton J. CD14-159 C allele is associated with increased risk of mortality after burn injury. Shock. 2007;27:232–7.
Barber R, Lemaire S, Burris A, Purdue G, Hunt J, Arnoldo B, et al. Epistatic interactions are critical to gene-association studies: PAI-1 and risk for mortality after burn injury. J Burn Care Res. 2008;29:168–75.
Huebinger R, Rivera-Chavez F, Liu M-M, Minei J, Purdue G, Hunt J, et al. IL-10 polymorphism associated with decreased risk for mortality after burn injury. J Surg Res. 2010;164:e141–5.
Shalhub S, Pham T, Gibran N, O’Keefe G. Tumor necrosis factor gene variation and the risk of mortality after burn injury: a cohort study. J Burn Care Res. 2009;30:105–11.
Barber RC, Aragaki CC, Rivera-Chavez FA, Purdue GF, Hunt JL, Horton JW. TLR4 and TNF-α polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet. 2004;41:808 LP–813.
Barber RC, Chang L-YE, Arnoldo BD, Purdue GF, Hunt JL, Horton JW, et al. Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin Med Res. 2006;4:250–5.
Uematsu S, Akira S. Toll-like receptors and innate immunity. J Mol Med. 2006;84:712–25.
Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282:2085–8.
Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004;5:987–95.
Long H, O’Connor B, Zemans R, Zhou X, Yang I, Schwartz D. The toll-like receptor 4 polymorphism Asp299Gly but not Thr399Ile influences TLR4 signaling and function. PLoS ONE. 2014;9:e93550.
Kuzmich N, Sivak K, Chubarev V, Porozov Y, Savateeva-Lyubimova T, Peri F. TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis. Vaccines. 2017;5:34.
Machida K, Cheng K, Sung V, Levine A, Foung S, Lai M, et al. Virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J Virol. 2006;80:866–74.
Lv S, Li J, Qiu X, Li W, Zhang C, Zhang Z-N, et al. A negative feedback loop of ICER and NF-κB regulates TLR signaling in innate immune responses. Cell Death Differ. 2017;24:492–9.
Medvedev A. Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer. J Interferon Cytokine Res. 2013;33:467–84.
Lin Y-T, Hodgkinson AV, Toll-Like CP. Receptors and human disease: lessons from single nucleotide polymorphisms. Curr Genomics. 2012;13:633–45.
Skevaki C, Pararas M, Kostelidou K, Tsakris A, Routsias JG. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases. Clin Exp Immunol. 2015;180:165–77.
Jessen KM, Lindboe SB, Petersen AL, Eugen-Olsen J, Benfield T. Common TNF-alpha, IL-1 beta, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from gram negative sepsis. BMC Infect Dis. 2007;7:108.
Wang M, Xu G, Lü L, Xu K, Chen Y, Pan H, et al. Genetic polymorphisms of IL-17A, IL-17F, TLR4 and miR-146a in association with the risk of pulmonary tuberculosis. Sci Rep. 2016;6:28586.
Budulac SE, Boezen HM, Hiemstra PS, Lapperre TS, Vonk JM, Timens W, et al. Toll-like receptor (TLR2 and TLR4) polymorphisms and chronic obstructive pulmonary disease. PLoS ONE. 2012;7:e43124.
Dai Y, Zhang Z, Xu L, Shang Y, Lu R, Chen J. Genetic polymorphisms of IL17A, TLR4 and P2RX7 and associations with the risk of chronic obstructive pulmonary disease. Mutat Res Toxicol Environ Mutagen. 2018;829–830:1–5.
Zhou J-G, Zhang J-P, Lee BH, Zhang S-L, Zhu L, Chen C. Toll-like receptor 4 polymorphisms in gram-negative bacterial infections of Han Chinese neonates. Am J Perinatol. 2015;32:363–70.
Ragnarsdóttir B, Jönsson K, Urbano A, Grönberg-Hernandez J, Lutay N, Tammi M, et al. Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection. PLoS ONE. 2010;5:e10734.
Lu KD, Radom-Aizik S, Haddad F, Zaldivar F, Kraft M, Cooper DM. Glucocorticoid receptor expression on circulating leukocytes differs between healthy male and female adults. J Clin Transl Sci. 2017;1:108–14.
Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M, et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 2002;16:61–71.
Lu NZ, Collins JB, Grissom SF, Cidlowski JA. Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor. Mol Cell Biol. 2007;27:7143–60.
Núñez Miguel R, Wong J, Westoll JF, Brooks HJ, O’Neill LAJ, Gay NJ, et al. A dimer of the toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins. PLoS ONE. 2007;2:e788.
Oakley RH, Cidlowski JA. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol. 2013;132:1033–44.
Vitellius G, Trabado S, Bouligand J, Delemer B, Lombès M. Pathophysiology of glucocorticoid signaling. Ann Endocrinol. 2018;79:98–106.
Kadmiel M, Cidlowski JA. Glucocorticoid receptor signaling in health and disease. Trends Pharm Sci. 2013;34:518–30.
Lu Y-C, Yeh W-C, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine. 2008;42:145–51.
Cahill CM, Rogers JT. Interleukin (IL) 1β induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IκB kinase α pathway targeting activator protein-1. J Biol Chem. 2008;283:25900–12.
Ott LW, Resing KA, Sizemore AW, Heyen JW, Cocklin RR, Pedrick NM, et al. Tumor necrosis factor-α- and interleukin-1-induced cellular responses: coupling proteomic and genomic information. J Proteome Res. 2007;6:2176–85.
Muñoz B, Suárez-Sánchez R, Hernández-Hernández O, Franco-Cendejas R, Cortés H, Magaña JJ. From traditional biochemical signals to molecular markers for detection of sepsis after burn injuries. Burns. 2019;45:16–31.
Castaño-Rodríguez N, Kaakoush NO, Pardo AL, Goh K-L, Fock KM, Mitchell HM. Genetic polymorphisms in the Toll-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer. Hum Immunol. 2014;75:808–15.
Jiao Y, Zhao J, Hu B, La X, Gong X, Huang Y, et al. Toll-like receptor 4 gene is associated with recurrent spontaneous miscarriage in Uygur and Han women in Xinjiang. Exp Ther Med. 2016;12:3268–74.
Kompoti M, Michopoulos A, Michalia M, Clouva-Molyvdas P-M, Germenis AE, Speletas M. Genetic polymorphisms of innate and adaptive immunity as predictors of outcome in critically ill patients. Immunobiology. 2015;220:414–21.
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–10.
Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. JAMA Intern Med. 2002;162:1028–32.
Figueroa L, Xiong Y, Song C, Piao W, Vogel SN, Medvedev AE. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF. J Immunol. 2012;188:4506–15.
Huang H, Wu J, Jin G, Zhang H, Ding Y, Hua Z, et al. A 5′-flanking region polymorphism in toll-like receptor 4 is associated with gastric cancer in a Chinese population. J Biomed Res. 2010;24:100–6.
Tongtawee T, Bartpho T, Kaewpitoon S, Kaewpitoon N, Dechsukhum C, Leeanansaksiri W, et al. Genetic polymorphisms in TLR1, TLR2, TLR4, and TLR10 of Helicobacter pylori-associated gastritis: a prospective cross-sectional study in Thailand. Eur J Cancer Prev. 2018;27:118–23.
Tongtawee T, Simawaranon T, Wattanawongdon W, Dechsukhum C, Leeanansaksiri W. Toll-like receptor 2 and 4 polymorphisms associated with Helicobacter pylori susceptibility and gastric cancer. Turk J Gastroenterol. 2019;30:15–20.
Oetting WS, Guan W, Schladt DP, Leduc RE, Jacobson PA, Matas AJ, et al. Donor polymorphisms of toll-like receptor 4 associated with graft failure in liver transplant recipients. Liver Transpl. 2012;18:1399–405. https://doi.org/10.1002/lt.23549.
Li P, He C-Y, Xu Q, Sun L-P, Ha M-W, Yuan Y. Effect of the -2081G/A polymorphism of the TLR4 gene and its interaction with Helicobacter pylori infection on the risk of gastric cancer in Chinese individuals. Genet Test Mol Biomark. 2014;18:610–5.
Greenhalgh DG, Saffle JR, Holmes James HIV, Gamelli RL, Palmieri TL, Horton JW, et al. American Burn Association Consensus Conference to define sepsis and infection in burns. J Burn Care Res. 2007;28:776–90. https://doi.org/10.1097/BCR.0b013e3181599bc9.
Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.
Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3:1101–8.
Excoffier L, Lischer HEL. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour. 2010;10:564–7.
This work was supported by CONACyT-México (grant number 2013-01-201918) to JJM. CACC is a doctoral student from the Doctorado en Investigación en Medicina program at the Instituto Politécnico Nacional (IPN)-Escuela Superior de Medicina in Mexico.
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Colín-Castro, C.A., Franco-Cendejas, R., Rocha-González, H.I. et al. Association of TLR4 gene polymorphisms with sepsis after a burn injury: findings of the functional role of rs2737190 SNP. Genes Immun 22, 24–34 (2021). https://doi.org/10.1038/s41435-021-00121-z